about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesPolyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionThe effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infectionSyk mediates BCR- and CD40-signaling integration during B cell activation.Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.B cell response is required for granuloma formation in the early infection of Schistosoma japonicum.B cells flying solo.A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells.Antigen receptor signals rescue B cells from TLR tolerance.Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.A Review of Intra- and Extracellular Antigen Delivery Systems for Virus Vaccines of Finfish.Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes.B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase.Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.Differential role of reactive oxygen species in the activation of mitogen-activated protein kinases and Akt by key receptors on B-lymphocytes: CD40, the B cell antigen receptor, and CXCR4.Piperine, a Pungent Alkaloid from Black Pepper, Inhibits B Lymphocyte Activation and Effector Functions.
P2860
Q24624348-9ACB9478-A855-41A8-98D1-B27518B5ED26Q33479167-56644DE2-26B8-478B-A98F-FBF06DC71203Q34545445-A6C22FA9-3F9F-4A7A-9E87-A9706DF24EBBQ34786499-DCF8DC4C-7ADC-4551-B2CD-0237A66F3E5FQ35609384-5A4B2F2C-1E9C-47E8-AD77-DE8AE584B48AQ36471300-CFD1304B-18C5-4D9B-80B4-7545CB234FC0Q37049026-BD9E444D-2418-4D37-A99E-AE70D0B345C9Q37350760-2046638C-AF86-45BD-9244-561B82F72489Q37460476-30DF088B-7124-401F-849A-026A8EFE80CEQ37684900-502AE5F0-954C-4C4C-9C4E-2E93DE718882Q38524859-DB18F1AC-541A-454A-97A2-1707D5F99680Q39474069-938CC92C-7378-4DAC-823D-A28882218DA5Q40329035-6CFEA47E-0EE8-4348-AC06-FBE3C67D771AQ40618791-6357D018-219D-45A1-97DD-EFEFCC7DA74AQ43076457-EC6B8952-1E0E-4C16-B108-C0530F2D8B99Q51182045-B9272900-F791-4F15-ADCA-D83CD1E126A3
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antigen-specific B-lymphocyte activation.
@ast
Antigen-specific B-lymphocyte activation.
@en
type
label
Antigen-specific B-lymphocyte activation.
@ast
Antigen-specific B-lymphocyte activation.
@en
prefLabel
Antigen-specific B-lymphocyte activation.
@ast
Antigen-specific B-lymphocyte activation.
@en
P2093
P1476
Antigen-specific B-lymphocyte activation
@en
P2093
Bruce S Hostager
Laura L Stunz
Sokol A Haxhinasto
P304
P356
10.1615/CRITREVIMMUNOL.V23.I3.10
P577
2003-01-01T00:00:00Z